Skip to Main Content

Paper Details

Accelerating drug access from advanced to early breast cancer: the special case of oral selective estrogen receptor degraders.
Curr Opin Oncol
0
2021
Author NameAffiliation
David W CesconPrincess Margaret Cancer Centre, University of Toronto
  • 1 - 1

Datasets

Release 1.2